Literature DB >> 26168721

Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

O Kovalchuk Ben-Zaken1, I Nissan2, S Tzaban2, A Taraboulos2, E Zcharia3, S Matzger4, I Shafat5, I Vlodavsky6, Y Tal4.   

Abstract

Cellular heparan sulfate (HS) has a dual role in scrapie pathogenesis; it is required for PrP(Sc) (scrapie prion protein) formation and facilitates infection of cells, mediating cellular uptake of prions. We examined the involvement of heparanase, a mammalian endoglycosidase degrading HS, in scrapie infection. In cultured cells, heparanase treatment or over-expression resulted in a profound decrease in PrP(Sc). Moreover, disease onset and progression were dramatically delayed in scrapie infected transgenic mice over-expressing heparanase. Together, our results provide direct in vivo evidence for the involvement of intact HS in the pathogenesis of prion disease and the protective role of heparanase both in terms of susceptibility to infection and disease progression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heparan sulfate; Heparanase; Prion disease; Scrapie prion protein; Survival time; Transgenic mice

Mesh:

Substances:

Year:  2015        PMID: 26168721      PMCID: PMC4532585          DOI: 10.1016/j.bbrc.2015.06.170

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Cellular heparan sulfate participates in the metabolism of prions.

Authors:  Olga Ben-Zaken; Salit Tzaban; Yuval Tal; Lior Horonchik; Jeffrey D Esko; Israel Vlodavsky; Albert Taraboulos
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

Review 2.  A short historical survey of developments in amyloid research.

Authors:  Mireille Dumoulina; Reto Bader
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

3.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 5.  Implications of heparan sulfate and heparanase in neuroinflammation.

Authors:  Xiao Zhang; Bo Wang; Jin-Ping Li
Journal:  Matrix Biol       Date:  2014-01-04       Impact factor: 11.583

Review 6.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

7.  Presence and role of glycosaminoglycans in amyloidosis.

Authors:  A Linker; H C Carney
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

8.  Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.

Authors:  Eyal Zcharia; Shula Metzger; Tova Chajek-Shaul; Helena Aingorn; Michael Elkin; Yael Friedmann; Talia Weinstein; Jin-Ping Li; Ulf Lindahl; Israel Vlodavsky
Journal:  FASEB J       Date:  2004-02       Impact factor: 5.191

9.  Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen.

Authors:  B Ehlers; H Diringer
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

Review 10.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

View more
  2 in total

1.  Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.

Authors:  Morikazu Imamura; Naoko Tabeta; Nobuko Kato; Yuichi Matsuura; Yoshifumi Iwamaru; Takashi Yokoyama; Yuichi Murayama
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

2.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.